» Articles » PMID: 33505528

Assessment of Genetically Modified Maize MON 87427 × MON 87460 × MON 89034 × 1507 × MON 87411 × 59122 and Subcombinations, for Food and Feed Uses, Under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2017-139)

Abstract

Maize MON 87427 × MON 87460 × MON 89034 × 1507 × MON 87411 × 59122 (six-event stack maize) was produced by conventional crossing to combine six single events: MON 87427, MON 87460, MON 89034, 1507, MON 87411 and 59122. The GMO Panel previously assessed the six single maize events and 17 of the subcombinations and did not identify safety concerns. No new data on the single maize events or the 17 subcombinations were identified that could lead to modification of the original conclusions on their safety. The molecular characterisation, comparative analysis (agronomic, phenotypic and compositional characteristics) and the outcome of the toxicological, allergenicity and nutritional assessment indicate that the combination of the single maize events and of the newly expressed proteins and dsRNA in the six-event stack maize does not give rise to food and feed safety and nutritional concerns. The GMO Panel concludes that the six-event stack maize, as described in this application, is as safe as its non-GM comparator and the selected non-GM reference varieties. In the case of accidental release of viable grains of the six-event stack maize into the environment, this would not raise environmental safety concerns. The GMO Panel assessed the likelihood of interactions among the single events in the 39 maize subcombinations not previously assessed and concludes that these are expected to be as safe as the single events, the previously assessed subcombinations and the six-event stack maize. The post-market environmental monitoring plan and reporting intervals are in line with the intended uses of the six-event stack maize. Post-market monitoring of food/feed is not considered necessary. The GMO Panel concludes that the six-event stack maize and its subcombinations are as safe as the non-GM comparator and the selected non-GM reference varieties with respect to potential effects on human and animal health and the environment.

Citing Articles

Assessment of genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 and 8 out of 10 of its subcombinations for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2022-9170).

Mullins E, Bresson J, Dalmay T, Dewhurst I, Epstein M, Firbank L EFSA J. 2024; 22(4):e8715.

PMID: 38686342 PMC: 11056846. DOI: 10.2903/j.efsa.2024.8715.


Comparative safety assessment of genetically modified crops: focus on equivalence with reference varieties could contribute to more efficient and effective field trials.

Kleter G, Voet H, Engel J, van der Berg J Transgenic Res. 2023; 32(4):235-250.

PMID: 37213044 PMC: 10409827. DOI: 10.1007/s11248-023-00344-y.


Facultative symbionts are potential agents of symbiont-mediated RNAi in aphids.

Li T, Wei Y, Zhao C, Li S, Gao S, Zhang Y Front Microbiol. 2022; 13:1020461.

PMID: 36504780 PMC: 9727308. DOI: 10.3389/fmicb.2022.1020461.


Assessment of genetically modified maize DP4114 × MON 89034 × MON 87411 × DAS-40278-9 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA GMO-NL-2020-171).

Mullins E, Bresson J, Dalmay T, Dewhurst I, Epstein M, Firbank L EFSA J. 2022; 20(11):e07619.

PMID: 36381120 PMC: 9644921. DOI: 10.2903/j.efsa.2022.7619.


Assessment of genetically modified maize MON 89034 × 1507 × MIR162 × NK603 × DAS-40278-9 for food and feed uses, under regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2018-151).

Mullins E, Bresson J, Dalmay T, Dewhurst I, Epstein M, Firbank L EFSA J. 2022; 20(8):e07451.

PMID: 35978615 PMC: 9373840. DOI: 10.2903/j.efsa.2022.7451.


References
1.
Wu G . Dietary requirements of synthesizable amino acids by animals: a paradigm shift in protein nutrition. J Anim Sci Biotechnol. 2014; 5(1):34. PMC: 4082180. DOI: 10.1186/2049-1891-5-34. View

2.
Pascher K . Spread of volunteer and feral maize plants in Central Europe: recent data from Austria. Environ Sci Eur. 2017; 28(1):30. PMC: 5202252. DOI: 10.1186/s12302-016-0098-1. View

3.
Trtikova M, Lohn A, Binimelis R, Chapela I, Oehen B, Zemp N . Teosinte in Europe - Searching for the Origin of a Novel Weed. Sci Rep. 2017; 7(1):1560. PMC: 5431553. DOI: 10.1038/s41598-017-01478-w. View

4.
Herrmann K . The Shikimate Pathway: Early Steps in the Biosynthesis of Aromatic Compounds. Plant Cell. 1995; 7(7):907-919. PMC: 160886. DOI: 10.1105/tpc.7.7.907. View

5.
Thompson C, Movva N, Tizard R, Crameri R, Davies J, Lauwereys M . Characterization of the herbicide-resistance gene bar from Streptomyces hygroscopicus. EMBO J. 1987; 6(9):2519-23. PMC: 553668. DOI: 10.1002/j.1460-2075.1987.tb02538.x. View